ALENTIS THERAPEUTICS TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND BIO INTERNALTIONAL CONVENTION

On May 31, 2023 Alentis Therapeutics ("Alentis"), the Claudin-1 company, reported its participation in the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) to be held June 2-6 in Chicago, IL, and the BIO International Convention to be held June 5-8 in Boston, MA (Press release, Alentis Therapeutics, MAY 31, 2023, View Source [SID1234632253]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Alentis management will be present at the conferences. In case you want to schedule a meeting please reach out via [email protected].